Skip to main content

LP 22 Pill - yellow round, 6mm

Pill with imprint LP 22 is Yellow, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Alvogen, Inc.

Methotrexate is used in the treatment of Acute Lymphoblastic Leukemia; Acute Lymphocytic Leukemia; Breast Cancer; Choriocarcinoma; Psoriatic Arthritis and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LP 22

Methotrexate Sodium

Imprint
LP 22
Strength
2.5 mg
Color
Yellow
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen, Inc.
National Drug Code (NDC)
47781-0482

Get help with Imprint Code FAQs.

Related images for "LP 22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.